======= NAF1 =======
== Gene Information ==
* **Official Symbol**: N/AF1
* **Official Name**: nuclear assembly factor 1 ribonucleoprotein
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=92345|92345]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96HR8|Q96HR8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NAF1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAF1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/617868|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: RNA-binding protein required for the maturation of box H/ACA snoRNPs complex and ribosome biogenesis. During assembly of the H/ACA snoRNPs complex, it associates with the complex and disappears during maturation of the complex and is replaced by NOLA1/GAR1 to yield mature H/ACA snoRNPs complex. Probably competes with NOLA1/GAR1 for binding with DKC1/NOLA4. {ECO:0000269|PubMed:16618814}.
|Gar1|
|box H/ACA snoRNP assembly|
|snoRNA guided rRNA pseudouridine synthesis|
|telomerase RNA stabilization|
|telomerase holoenzyme complex assembly|
|rRNA pseudouridine synthesis|
|small nucleolar ribonucleoprotein complex|
|small nucleolar ribonucleoprotein complex assembly|
|positive regulation of telomerase RNA localization to Cajal body|
|pseudouridine synthesis|
|regulation of telomerase RNA localization to Cajal body|
|telomerase RNA binding|
|positive regulation of telomere maintenance via telomerase|
|positive regulation of telomerase activity|
|rRNA modification|
|positive regulation of telomere maintenance via telomere lengthening|
|RNA stabilization|
|positive regulation of telomere maintenance|
|regulation of telomerase activity|
|regulation of telomere maintenance via telomerase|
|negative regulation of RNA catabolic process|
|regulation of telomere maintenance via telomere lengthening|
|positive regulation of DNA biosynthetic process|
|regulation of telomere maintenance|
|regulation of DNA biosynthetic process|
|RNA modification|
|positive regulation of chromosome organization|
|regulation of RNA stability|
|positive regulation of DNA metabolic process|
|rRNA processing|
|rRNA metabolic process|
|ribonucleoprotein complex assembly|
|ribonucleoprotein complex subunit organization|
|negative regulation of cellular catabolic process|
|ribosome biogenesis|
|negative regulation of catabolic process|
|regulation of chromosome organization|
|regulation of DNA metabolic process|
|ncRNA processing|
|ribonucleoprotein complex biogenesis|
|ncRNA metabolic process|
|posttranscriptional regulation of gene expression|
|positive regulation of organelle organization|
|positive regulation of transferase activity|
|regulation of cellular catabolic process|
|cellular protein-containing complex assembly|
|RNA processing|
|regulation of transferase activity|
|regulation of catabolic process|
|positive regulation of cellular component organization|
|regulation of organelle organization|
|negative regulation of RNA metabolic process|
|RNA binding|
|positive regulation of catalytic activity|
|negative regulation of nucleobase-containing compound metabolic process|
|protein-containing complex assembly|
|RNA metabolic process|
|positive regulation of molecular function|
|protein-containing complex subunit organization|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-2.29|
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|-2.06|
|[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|-1.94|
^Gene^Correlation^
|[[:human genes:a:adsl|ADSL]]|0.504|
|[[:human genes:z:zrsr2|ZRSR2]]|0.476|
|[[:human genes:r:rpp21|RPP21]]|0.466|
|[[:human genes:r:rnmt|RNMT]]|0.458|
|[[:human genes:t:thg1l|THG1L]]|0.452|
|[[:human genes:t:txnl4b|TXNL4B]]|0.449|
|[[:human genes:r:rptor|RPTOR]]|0.431|
|[[:human genes:u:utp23|UTP23]]|0.427|
|[[:human genes:g:gmppb|GMPPB]]|0.426|
|[[:human genes:h:hspd1|HSPD1]]|0.415|
|[[:human genes:g:gtf3c3|GTF3C3]]|0.411|
|[[:human genes:e:exoc4|EXOC4]]|0.408|
|[[:human genes:y:yars|YARS]]|0.408|
|[[:human genes:a:atp5o|ATP5O]]|0.406|
|[[:human genes:r:rpe|RPE]]|0.404|
Global Fraction of Cell Lines Where Essential: 27/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|1/1|
|bile duct|1/28|
|blood|0/28|
|bone|0/26|
|breast|1/33|
|central nervous system|1/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|2/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|2/21|
|liver|0/20|
|lung|1/75|
|lymphocyte|0/16|
|ovary|1/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|4/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|2/22|
|urinary tract|4/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3913
* **Expression level (log2 read counts)**: 4.86
{{:chemogenomics:nalm6 dist.png?nolink |}}